Robert Iannone

6.2k citations
35 papers · 4.8k · 4 hit papers · h-index 22

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • PARP inhibition in cancer therapy
    • Cutaneous Melanoma Detection and Management
  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research

Papers in

    • Hematopoietic Stem Cell Transplantation 7
    • Acute Myeloid Leukemia Research 2
    • Hemoglobinopathies and Related Disorders 3

Robert Iannone

35 papers receiving 4.6k citations

Robert Iannone's Hit Papers

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer 2019 · 704 citations
7040+4+8Years since publication5001k1.5k

Peers

Robert Iannone
Comparison fields: 5 of 92
  • Oncology 2.2k
  • Hematology 802
  • Cancer Research 369
  • Genetics 235
  • Immunology 312
Replace Jochen Buechner with:
Jochen Buechner Norway
Hermann Josef Vormoor Germany
Albrecht Reichle Germany
Judith Grob Villablanca United States
He-Jing Wang United States
Kieron M. Dunleavy United States
Benjamin Esterni France
Januario E. Castro United States
Bijal Dinesh Shah United States
Christoph Renner Switzerland
Robert Iannone relative to Jochen Buechner Norway Jochen Buechner's profile →
Citations per field
00.5×2×4×5.6×
Jochen Buechner · 1×
Citations per year

Countries citing papers authored by Robert Iannone

Since Specialization
Citations

This map shows the geographic impact of Robert Iannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Iannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Iannone more than expected).

Fields of papers citing papers by Robert Iannone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Iannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Iannone. The network helps show where Robert Iannone may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Iannone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Iannone Line = papers co-authored together Robert Iannone links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Hit paper breakdown →
20141539
2
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Hit paper breakdown →
2019704
3
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Hit paper breakdown →
2015672
4
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Hit paper breakdown →
2013480
5 2001286
6 2003225
7 2011171
8 2002102
9 200690
10 201549
11 200146
12 199237
13 201136
14 201436
15 202533
16 199531
17
The Harriet Lane handbook : a manual for pediatric house officers
200029
18 202226
19 201325
20 201625

About Robert Iannone

Robert Iannone is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 35 papers that have together received 4.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), T-cell and Retrovirus Studies (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Antifungal resistance and susceptibility (2 papers), Acute Myeloid Leukemia Research (2 papers) and Health and Medical Research Impacts (2 papers). The work is most often cited by research in Oncology (2.2k citations), Hematology (802 citations), Cancer Research (369 citations), Genetics (235 citations) and Immunology (312 citations). Robert Iannone has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ephraim Joseph Fuchs, Leo Luznik, Laura Engstrom, Sanju Jalla, Alessandro Davide Santin, Aditya Bardia, Kevin M. Kalinsky, Vandana Gupta Abramson, William A. Wegener and Nikita C. Shah. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Clinical Cancer Research, Pediatric Blood & Cancer and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact